Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
Germany's drug-pricing investigation does not limit a future Section 301 tariff list to medicines, and a new comment asks USTR to target other German sectors. USTR has yet to name a product, rate, or effective date.